ARCHIVES

Risk of Relapse Continues After Five Years of Therapy

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI to Undergo More GAO Probes

July 15, 1977

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008